Healthcare Providers and Services
Company Overview of National Institutes of Health
National Institutes of Health operates as a medical research agency in the United States. It offers services for conducting and supporting basic, clinical, and translational medical research; and investigates the causes, treatments, and cures for common and rare diseases. The company also provides leadership and direction to programs designed to improve the health by conducting and supporting research in the causes, diagnosis, prevention, and cure of human diseases; in the processes of human growth and development; in the biological effects of environmental contaminants; in the understanding of mental, addictive, and physical disorders; and in directing programs for the collection, dissemina...
9000 Rockville Pike
Bethesda, MD 20892
Founded in 1887
Key Executives for National Institutes of Health
Chief Financial Officer and Deputy Director of Management
Chief Information Officer
Deputy Director of Extramural Research
Deputy Director of Intramural Research
Compensation as of Fiscal Year 2014.
National Institutes of Health Key Developments
National Institutes of Health Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 05:00 PM
Jan 9 15
National Institutes of Health Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 05:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Francis S. Collins, Director.
National Institutes of Health Partners with Vtesse to Develop Treatments for an Often-Fatal Group of Disorders Known as Lysosomal Storage Diseases
Jan 7 15
The National Institutes of Health in Bethesda has partnered with Vtesse Inc. to develop treatments for an often-fatal group of disorders known as lysosomal storage diseases. Vtesse is providing funding for a phase 1 clinical trial of a treatment for Niemann-Pick Disease Type C and other lysosomal storage diseases, which will be conducted at the NIH Clinical Center. The study is led by researchers at the National Center for Advancing Translational Sciences and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, which are both part of the NIH. There are about 50 lysosomal storage diseases, also known as lipid storage diseases, which are inherited, rare disorders that usually affect children. They cause fatty materials to accumulate in the body's cells and tissues, often resulting in damage to the brain, peripheral nervous system, liver and other organs and tissues. Researchers have been evaluating the safety of a drug called cyclodextrin. Vtesse is supporting that ongoing study, and due to the new agreement, will also help fund a second clinical study of cyclodextrin in this country and Europe. That study is expected to begin sometime this year.
National Institutes of Health Presents at BioFlorida Annual Conference, Oct-13-2014 11:30 AM
Oct 11 14
National Institutes of Health Presents at BioFlorida Annual Conference, Oct-13-2014 11:30 AM. Venue: Harbor Beach Marriott, Ft. Lauderdale, Florida, United States. Speakers: Sitta Sittapalam, Senior Scientific Officer & Project Manager.
Similar Private Companies By Industry
Recent Private Companies Transactions